High Infusion Rate Study of Immunoglobulin Intravenous (Human) 10% (NewGam)

Clinical trial NCT01313507 · COMPLETED

Trial details

NCT number: NCT01313507
Sponsor: Octapharma
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Immunodeficiency Disease

Start date: 2011-05-01
Primary completion: 2012-09-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.